James A. Geraghty - 12 Dec 2024 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PVLA)

Role: Director
Signature: /s/ Thomas Bures, Attorney-in-Fact
Issuer symbol: PVLA
Transactions as of: 12 Dec 2024
Net transactions value: -$0.01
Form type: 4
Filing time: 12 Dec 2024, 16:16:43 UTC
Previous filing: 28 Oct 2024
Next filing: 04 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PIRS	Series F Preferred Stock, par value $0.001 per share	Disposed to Issuer	$0.01	-1	-100%	$0.0100	0	12 Dec 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 4 relates to the redemption of the Series F Preferred Stock, par value $0.001, that was issued to James A. Geraghty on August 7, 2024. The Series F Preferred Stock was redeemed by Pieris Pharmaceuticals, Inc. for $0.01 automatically and effective immediately after the effectiveness of its Authorized Share Increase, as set forth in the Certificate of Designation of Series F Preferred Stock.

Content

This Form 4 relates to the redemption of the Series F Preferred Stock, par value $0.001, that was issued to James A. Geraghty on August 7, 2024. The Series F Preferred Stock was redeemed by Pieris Pharmaceuticals, Inc. for $0.01 automatically and effective immediately after the effectiveness of its Authorized Share Increase, as set forth in the Certificate of Designation of Series F Preferred Stock.